Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

64 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
High frequency of BRCA1, but not CHEK2 or NBS1 (NBN), founder mutations in Russian ovarian cancer patients.
Suspitsin EN, Sherina NY, Ponomariova DN, Sokolenko AP, Iyevleva AG, Gorodnova TV, Zaitseva OA, Yatsuk OS, Togo AV, Tkachenko NN, Shiyanov GA, Lobeiko OS, Krylova NY, Matsko DE, Maximov SY, Urmancheyeva AF, Porhanova NV, Imyanitov EN. Suspitsin EN, et al. Hered Cancer Clin Pract. 2009 Feb 25;7(1):5. doi: 10.1186/1897-4287-7-5. Hered Cancer Clin Pract. 2009. PMID: 19338682 Free PMC article.
Evidence for microsatellite instability in bilateral breast carcinomas.
Imyanitov EN, Togo AV, Suspitsin EN, Grigoriev MY, Pozharisski KM, Turkevich EA, Hanson KP, Hayward NK, Chenevix-Trench G, Theillet C, Lavin MF. Imyanitov EN, et al. Among authors: suspitsin en. Cancer Lett. 2000 Jun 1;154(1):9-17. doi: 10.1016/s0304-3835(99)00444-9. Cancer Lett. 2000. PMID: 10799734
CYP17 polymorphism in the groups of distinct breast cancer susceptibility: comparison of patients with the bilateral disease vs. monolateral breast cancer patients vs. middle-aged female controls vs. elderly tumor-free women.
Kuligina ES, Togo AV, Suspitsin EN, Grigoriev MY, Pozharisskiy KM, Chagunava OL, Berstein LM, Theillet C, Hanson KP, Imyanitov EN. Kuligina ES, et al. Among authors: suspitsin en. Cancer Lett. 2000 Aug 1;156(1):45-50. doi: 10.1016/s0304-3835(00)00436-5. Cancer Lett. 2000. PMID: 10840158
CYP19 gene polymorphism in endometrial cancer patients.
Berstein LM, Imyanitov EN, Suspitsin EN, Grigoriev MY, Sokolov EP, Togo A, Hanson KP, Poroshina TE, Vasiljev DA, Kovalevskij AY, Gamajunova VB. Berstein LM, et al. Among authors: suspitsin en. J Cancer Res Clin Oncol. 2001 Feb;127(2):135-8. doi: 10.1007/s004320000200. J Cancer Res Clin Oncol. 2001. PMID: 11216915
Tissue transglutaminase expression in breast carcinomas.
Grigoriev MY, Suspitsin EN, Togo AV, Pozharisski KM, Ivanova OA, Nardacci R, Falasca L, Piacentini M, Imyanitov EN, Hanson KP. Grigoriev MY, et al. Among authors: suspitsin en. J Exp Clin Cancer Res. 2001 Jun;20(2):265-8. J Exp Clin Cancer Res. 2001. PMID: 11484985
Improved reliability of allele-specific PCR.
Imyanitov EN, Buslov KG, Suspitsin EN, Kuligina ESh, Belogubova EV, Grigoriev MY, Togo AV, Hanson KP. Imyanitov EN, et al. Among authors: suspitsin en. Biotechniques. 2002 Sep;33(3):484, 486, 488 passim. doi: 10.2144/02333bm04. Biotechniques. 2002. PMID: 12238755 Free article. No abstract available.
Evidence against involvement of p53 polymorphism in breast cancer predisposition.
Suspitsin EN, Buslov KG, Grigoriev MY, Ishutkina JG, Ulibina JM, Gorodinskaya VM, Pozharisski KM, Berstein LM, Hanson KP, Togo AV, Imyanitov EN. Suspitsin EN, et al. Int J Cancer. 2003 Jan 20;103(3):431-3. doi: 10.1002/ijc.10834. Int J Cancer. 2003. PMID: 12471629 Review. No abstract available.
64 results